Silicon Canals has published a list of the 9 best health tech startups in Belgium. 4 of them are located in the Leuven MindGate region: miDiagnostics, reMYND, Biocartis and icometrix. Silicon Canals is the leading English language technology media source for the Benelux and across Europe.
"Health tech is an undisputed leader in the startup landscape in Belgium outranking industries such as fintech and manufacturing", says Silicon Canals. "There has been a persistent growth in the health tech startups in the country since the past decade. Not only startups but also in the scaleup ecosystem, healthcare is a leader in Belgium. Mostly, a large number of Belgium health tech startups are spin-offs that have budded from research organisations. Furthermore, many initiatives and networks are also providing their support to healthcare entrepreneurship."
We are very proud that 4 out of 9 nominees are based in Leuven and are a member of the Leuven MindGate community. It shows that our health tech startups and scale-ups are being noticed
You can read the full article on the website of Silicon Canals.
miDiagnostics is a spin-off from imec and a research collaboration with the Johns Hopkins University in the US. The Leuven-based healthtech company is developing a new generation of disposable tests that need only drops of blood for the detection of cells, nucleic acids, proteins, and small molecules. It uses a novel silicon-based nanofluidic processor that is capable of processing the blood sample automatically sans any pumps or valves. With miDiagnostics, there is no need for expensive and complex instrumentation to make medical decisions. The nanofluidic processor is combined with a compact reader for screening, diagnosis and monitoring of a range of health conditions including infectious ailments.
reMYND is a spin-off from the University of Leuven. It actively drives R&D in the field of protein misfolding diseases, among others Alzheimer’s disease (AD) and Parkinson’s disease (PD). The company consists of two independently managed units. The Drug Discovery and Development Unit focuses on disease-modifying treatments for among others AD and PD. And, the Contract Research Unit offers extensive experience in the testing of experimental Alzheimer therapies in its unique and proprietary transgenic mouse models.
Leuven-based icometrix has developed a fully automated FDA-approved and CE-certified icobrain software. Its software is already available in Europe, Brazil, Australia, Canada, and Japan. The icobrain software is deployed in over 100 hospitals and imaging centre networks all over the world and is working with the largest health tech and pharmaceutical companies as well.
icometrix touts that its icobrain software paves the way for a better and faster understanding of medical images in a more consistent and personalised manner by quantifying the volume of brain structures and abnormalities. This software is of critical importance as brain scan plays a major role in the diagnosis and treatment of various disorders in an efficient way.
Biocartis develops diagnostic systems to reduce the cost and improve the efficacy of personalised medical treatments. It provides next-generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry.
The company’s proprietary MDx Idylla platform is a fully automated, real-time system offering accurate, highly-reliable molecular information from any biological sample in virtually any setting. Idylla addresses the growing demand for personalised medicine by allowing fast and effective treatment selection and treatment progress monitoring.
All source credits go to Silicon Canals.
Picture Biocartis: copyright De Tijd